Medicine Man Technologies, Inc., to Present at Sidoti & Company, LLC, Spring 2019 Investor Conference

DENVER, March 21, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated cannabis operator, today announced it will be presenting at the Sidoti & Company, LLC, Spring 2019 Investor Conference being held on March 28, 2019, at the Marriott Marquis in New York City.  

Joe Puglise, COO of Medicine Man Technologies, will be delivering a corporate overview of the Company on Thursday, March 28, at 8:00AM ET. Mr. Puglise will also be available for one-on-one meetings with investors.  

"We've announced some recent corporate updates to our Company, including 150%+ year-over-year profitable growth and the pending acquisitions of MedPharm Holdings, LLC, and Medicine Man Denver, which would bring Medicine Man Technologies to an annual run rate of over $40 million," says Medicine Man Technologies CEO Andy Williams. "Along with our new COO's expertise in scaling up businesses, there are many reasons why we believe this is an exciting time to tell our story to the investment community."

For more information about Medicine Man Technologies, please visit:

https://www.medicinemantechnologies.com/

About Sidoti & Company, LLC, Spring 2019 Investor Conference
Sidoti & Company, LLC, is a leading Wall Street provider of small- and micro-cap securities research, covering almost 200 equities. We help issuers in this sector build interest and visibility through our relationships with over 500 Institutional Investors, Family Offices and High Net Worth Individuals. Sidoti & Company, LLC, aims to unite publicly traded companies with quality investors.

About Medicine Man Technologies
Medicine Man Technologies is a fully integrated operator in the cannabis industry, offering consulting, retail pharma-grade products, and turnkey solutions for cannabis cultivators for over a decade. Medicine Man Technologies is leveraging its expertise and intellectual property to vertically integrate retail, cultivation, formulation, and distribution operations. The Company's client portfolio includes active and past clients in 18 states and seven countries. 

Forward-looking Statements
This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own, or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; and (v) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

CONTACT: Investor Relations Contact: [email protected], 1-866-348-1997

SOURCE Medicine Man Technologies Inc.

Related Links

http://www.medicinemantechnologies.com